Suppr超能文献

内皮细胞对血管性血友病因子的降解

Reduction of von Willebrand factor by endothelial cells.

作者信息

Xie L, Chesterman C N, Hogg P J

机构信息

Centre for Thrombosis and Vascular Research, School of Pathology, University of New South Wales, Sydney, Australia.

出版信息

Thromb Haemost. 2000 Sep;84(3):506-13.

Abstract

The haemostatic activity of plasma von Willebrand factor (vWF) is a function of multimer size. Only the large vWF multimers are effective in promoting platelet adhesion to a site of vascular injury. We observed that the conditioned medium of cultured human umbilical vein, human microvascular and bovine aortic endothelial cells contained an activity which reduced the average multimer size of plasma or purified vWF. The average multimer size of vWF produced endogenously by human umbilical vein endothelial cells was similarly reduced following secretion. The reducing activity was ablated by pre-treatment with heat or the thiol blocking agents. iodoacetamide, N-ethylmaleimide or E-64, but not by a range of specific serine-, cysteine-, aspartic-, or metalloproteinase inhibitors. Reduction in vWF multimer size was associated with formation of new thiols in vWF and there was no evidence for additional proteolytic processing of vWF. The reducing activity was associated with a protein with an anionic pi that binds heparin and contains reactive thiol(s). These results suggested that the interchain disulfide bonds that link the vWF homodimers near the N-termini were being reduced by a vWF reductase secreted by endothelial cells. In support of this hypothesis, incubation of vWF with the protein reductants, protein disulfide isomerase and thioredoxin, resulted in formation of new thiols in vWF and reduction in the average multimer size of vWF. These findings may have consequences for control of vWF haemostatic activity.

摘要

血浆血管性血友病因子(vWF)的止血活性是多聚体大小的函数。只有大的vWF多聚体在促进血小板黏附于血管损伤部位方面有效。我们观察到,培养的人脐静脉、人微血管和牛主动脉内皮细胞的条件培养基含有一种活性物质,可降低血浆或纯化vWF的平均多聚体大小。人脐静脉内皮细胞内源性产生的vWF在分泌后其平均多聚体大小也同样降低。该还原活性可通过加热或硫醇阻断剂碘乙酰胺、N-乙基马来酰亚胺或E-64预处理而被消除,但一系列特异性丝氨酸、半胱氨酸、天冬氨酸或金属蛋白酶抑制剂不能消除该活性。vWF多聚体大小的降低与vWF中新硫醇的形成有关,且没有证据表明vWF有额外的蛋白水解加工。该还原活性与一种具有阴离子π值、能结合肝素并含有反应性硫醇的蛋白质有关。这些结果表明,在内皮细胞分泌的一种vWF还原酶作用下,连接N端附近vWF同二聚体的链间二硫键正在被还原。为支持这一假设,将vWF与蛋白质还原剂、蛋白质二硫键异构酶和硫氧还蛋白一起孵育,导致vWF中新硫醇的形成以及vWF平均多聚体大小的降低。这些发现可能对vWF止血活性的控制产生影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验